United States Nuclear Medicine Diagnostics Market Report 2017

February 2017 | 118 pages | ID: U08ECA46513EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Nuclear Medicine Diagnostics

Revenue, means the sales value of Nuclear Medicine Diagnostics

This report studies sales (consumption) of Nuclear Medicine Diagnostics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Agfa-Gevaert
• Cardiarc
• Digirad Corporation
• Gamma Medica
• GE Healthcare
• Hologic
• BC Technical
• CMR Naviscan
• Positron Corporation
• Segami Corporation
• Philips Healthcare
• Siemens

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by applications, this report focuses on sales, market share and growth rate of Nuclear Medicine Diagnostics in each application, can be divided into

• Application 1
• Application 2

Contents

United States Nuclear Medicine Diagnostics Market Report 2017

1 NUCLEAR MEDICINE DIAGNOSTICS OVERVIEW

1.1 Product Overview and Scope of Nuclear Medicine Diagnostics
1.2 Classification of Nuclear Medicine Diagnostics
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Nuclear Medicine Diagnostics
  1.3.1 Application
  1.3.2 Application
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Nuclear Medicine Diagnostics (2012-2022)
  1.4.1 United States Nuclear Medicine Diagnostics Sales and Growth Rate (2012-2022)
  1.4.2 United States Nuclear Medicine Diagnostics Revenue and Growth Rate (2012-2022)

2 UNITED STATES NUCLEAR MEDICINE DIAGNOSTICS COMPETITION BY MANUFACTURERS

2.1 United States Nuclear Medicine Diagnostics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Nuclear Medicine Diagnostics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Nuclear Medicine Diagnostics Average Price by Manufactures (2015 and 2016)
2.4 Nuclear Medicine Diagnostics Market Competitive Situation and Trends
  2.4.1 Nuclear Medicine Diagnostics Market Concentration Rate
  2.4.2 Nuclear Medicine Diagnostics Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES NUCLEAR MEDICINE DIAGNOSTICS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Nuclear Medicine Diagnostics Sales and Market Share by States (2012-2017)
3.2 United States Nuclear Medicine Diagnostics Revenue and Market Share by States (2012-2017)
3.3 United States Nuclear Medicine Diagnostics Price by States (2012-2017)

4 UNITED STATES NUCLEAR MEDICINE DIAGNOSTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Nuclear Medicine Diagnostics Sales and Market Share by Type (2012-2017)
4.2 United States Nuclear Medicine Diagnostics Revenue and Market Share by Type (2012-2017)
4.3 United States Nuclear Medicine Diagnostics Price by Type (2012-2017)
4.4 United States Nuclear Medicine Diagnostics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES NUCLEAR MEDICINE DIAGNOSTICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Nuclear Medicine Diagnostics Sales and Market Share by Application (2012-2017)
5.2 United States Nuclear Medicine Diagnostics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES NUCLEAR MEDICINE DIAGNOSTICS MANUFACTURERS PROFILES/ANALYSIS

6.1 Agfa-Gevaert
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Agfa-Gevaert Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Cardiarc
  6.2.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Cardiarc Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Digirad Corporation
  6.3.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Digirad Corporation Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Gamma Medica
  6.4.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Gamma Medica Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GE Healthcare
  6.5.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GE Healthcare Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Hologic
  6.6.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Hologic Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 BC Technical
  6.7.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 BC Technical Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 CMR Naviscan
  6.8.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 CMR Naviscan Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Positron Corporation
  6.9.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Positron Corporation Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Segami Corporation
  6.10.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Segami Corporation Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Philips Healthcare
6.12 Siemens

7 NUCLEAR MEDICINE DIAGNOSTICS MANUFACTURING COST ANALYSIS

7.1 Nuclear Medicine Diagnostics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nuclear Medicine Diagnostics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nuclear Medicine Diagnostics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nuclear Medicine Diagnostics Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NUCLEAR MEDICINE DIAGNOSTICS MARKET FORECAST (2017-2022)

11.1 United States Nuclear Medicine Diagnostics Sales, Revenue Forecast (2017-2022)
11.2 United States Nuclear Medicine Diagnostics Sales Forecast by Type (2017-2022)
11.3 United States Nuclear Medicine Diagnostics Sales Forecast by Application (2017-2022)
11.4 Nuclear Medicine Diagnostics Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Nuclear Medicine Diagnostics
Table Classification of Nuclear Medicine Diagnostics
Figure United States Sales Market Share of Nuclear Medicine Diagnostics by Type in 2015
Table Application of Nuclear Medicine Diagnostics
Figure United States Sales Market Share of Nuclear Medicine Diagnostics by Application in 2015
Figure United States Nuclear Medicine Diagnostics Sales and Growth Rate (2012-2022)
Figure United States Nuclear Medicine Diagnostics Revenue and Growth Rate (2012-2022)
Table United States Nuclear Medicine Diagnostics Sales of Key Manufacturers (2015 and 2016)
Table United States Nuclear Medicine Diagnostics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Nuclear Medicine Diagnostics Sales Share by Manufacturers
Figure 2016 Nuclear Medicine Diagnostics Sales Share by Manufacturers
Table United States Nuclear Medicine Diagnostics Revenue by Manufacturers (2015 and 2016)
Table United States Nuclear Medicine Diagnostics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Nuclear Medicine Diagnostics Revenue Share by Manufacturers
Table 2016 United States Nuclear Medicine Diagnostics Revenue Share by Manufacturers
Table United States Market Nuclear Medicine Diagnostics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Nuclear Medicine Diagnostics Average Price of Key Manufacturers in 2015
Figure Nuclear Medicine Diagnostics Market Share of Top 3 Manufacturers
Figure Nuclear Medicine Diagnostics Market Share of Top 5 Manufacturers
Table United States Nuclear Medicine Diagnostics Sales by States (2012-2017)
Table United States Nuclear Medicine Diagnostics Sales Share by States (2012-2017)
Figure United States Nuclear Medicine Diagnostics Sales Market Share by States in 2015
Table United States Nuclear Medicine Diagnostics Revenue and Market Share by States (2012-2017)
Table United States Nuclear Medicine Diagnostics Revenue Share by States (2012-2017)
Figure Revenue Market Share of Nuclear Medicine Diagnostics by States (2012-2017)
Table United States Nuclear Medicine Diagnostics Price by States (2012-2017)
Table United States Nuclear Medicine Diagnostics Sales by Type (2012-2017)
Table United States Nuclear Medicine Diagnostics Sales Share by Type (2012-2017)
Figure United States Nuclear Medicine Diagnostics Sales Market Share by Type in 2015
Table United States Nuclear Medicine Diagnostics Revenue and Market Share by Type (2012-2017)
Table United States Nuclear Medicine Diagnostics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nuclear Medicine Diagnostics by Type (2012-2017)
Table United States Nuclear Medicine Diagnostics Price by Type (2012-2017)
Figure United States Nuclear Medicine Diagnostics Sales Growth Rate by Type (2012-2017)
Table United States Nuclear Medicine Diagnostics Sales by Application (2012-2017)
Table United States Nuclear Medicine Diagnostics Sales Market Share by Application (2012-2017)
Figure United States Nuclear Medicine Diagnostics Sales Market Share by Application in 2015
Table United States Nuclear Medicine Diagnostics Sales Growth Rate by Application (2012-2017)
Figure United States Nuclear Medicine Diagnostics Sales Growth Rate by Application (2012-2017)
Table Agfa-Gevaert Basic Information List
Table Agfa-Gevaert Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Agfa-Gevaert Nuclear Medicine Diagnostics Sales Market Share (2012-2017)
Table Cardiarc Basic Information List
Table Cardiarc Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Cardiarc Nuclear Medicine Diagnostics Sales Market Share (2012-2017)
Table Digirad Corporation Basic Information List
Table Digirad Corporation Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Digirad Corporation Nuclear Medicine Diagnostics Sales Market Share (2012-2017)
Table Gamma Medica Basic Information List
Table Gamma Medica Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Gamma Medica Nuclear Medicine Diagnostics Sales Market Share (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Table GE Healthcare Nuclear Medicine Diagnostics Sales Market Share (2012-2017)
Table Hologic Basic Information List
Table Hologic Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Hologic Nuclear Medicine Diagnostics Sales Market Share (2012-2017)
Table BC Technical Basic Information List
Table BC Technical Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Table BC Technical Nuclear Medicine Diagnostics Sales Market Share (2012-2017)
Table CMR Naviscan Basic Information List
Table CMR Naviscan Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Table CMR Naviscan Nuclear Medicine Diagnostics Sales Market Share (2012-2017)
Table Positron Corporation Basic Information List
Table Positron Corporation Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Positron Corporation Nuclear Medicine Diagnostics Sales Market Share (2012-2017)
Table Segami Corporation Basic Information List
Table Segami Corporation Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Segami Corporation Nuclear Medicine Diagnostics Sales Market Share (2012-2017)
Table Philips Healthcare Basic Information List
Table Siemens Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine Diagnostics
Figure Manufacturing Process Analysis of Nuclear Medicine Diagnostics
Figure Nuclear Medicine Diagnostics Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine Diagnostics Major Manufacturers in 2015
Table Major Buyers of Nuclear Medicine Diagnostics
Table Distributors/Traders List
Figure United States Nuclear Medicine Diagnostics Production and Growth Rate Forecast (2017-2022)
Figure United States Nuclear Medicine Diagnostics Revenue and Growth Rate Forecast (2017-2022)
Table United States Nuclear Medicine Diagnostics Production Forecast by Type (2017-2022)
Table United States Nuclear Medicine Diagnostics Consumption Forecast by Application (2017-2022)
Table United States Nuclear Medicine Diagnostics Sales Forecast by States (2017-2022)
Table United States Nuclear Medicine Diagnostics Sales Share Forecast by States (2017-2022)